Information
A new option for long-term blood sugar control ...
For patients with type 2 diabetes, long-term medication to control blood sugar is a big challenge. Traditional hypoglycemic drugs need to be taken multiple times a day, which is not...
A new option for long-term blood sugar control ...
For patients with type 2 diabetes, long-term medication to control blood sugar is a big challenge. Traditional hypoglycemic drugs need to be taken multiple times a day, which is not...
Beware! Five types of people who should never t...
Lemborexant is a new insomnia treatment drug that has attracted much attention in recent years. It has become a new choice for many insomnia patients due to its unique mechanism...
Beware! Five types of people who should never t...
Lemborexant is a new insomnia treatment drug that has attracted much attention in recent years. It has become a new choice for many insomnia patients due to its unique mechanism...
Guide to using Lepore during the growth period:...
"Will this sleeping pill be addictive?" "After taking Lebrexan for a month, will my insomnia become worse if I suddenly stop taking it?" As a new type of orexin receptor...
Guide to using Lepore during the growth period:...
"Will this sleeping pill be addictive?" "After taking Lebrexan for a month, will my insomnia become worse if I suddenly stop taking it?" As a new type of orexin receptor...
Beware! A complete guide to the risks of drug i...
As the clinical application of GLP-1 drugs in the field of glucose reduction and weight loss continues to heat up, the new generation of dual receptor agonist Tirzepatide has attracted...
Beware! A complete guide to the risks of drug i...
As the clinical application of GLP-1 drugs in the field of glucose reduction and weight loss continues to heat up, the new generation of dual receptor agonist Tirzepatide has attracted...
Traditional hypoglycemic drugs have poor effect...
🔍 Three major dilemmas of traditional hypoglycemic drugs The 2023 China Diabetes Diagnosis and Treatment Survey shows that among patients using traditional glucose-lowering drugs: ● 42% of people are troubled...
Traditional hypoglycemic drugs have poor effect...
🔍 Three major dilemmas of traditional hypoglycemic drugs The 2023 China Diabetes Diagnosis and Treatment Survey shows that among patients using traditional glucose-lowering drugs: ● 42% of people are troubled...
In-depth analysis of oral and injectable semagl...
With the continuous development of diabetes treatment, the launch of semaglutide oral tablets in 2025 will bring new treatment options to patients. This article will comprehensively compare the characteristics of...
In-depth analysis of oral and injectable semagl...
With the continuous development of diabetes treatment, the launch of semaglutide oral tablets in 2025 will bring new treatment options to patients. This article will comprehensively compare the characteristics of...